Author: Marty, Francisco M; Chemaly, Roy F; Mullane, Kathleen M; Lee, Dong-Gun; Hirsch, Hans H; Small, Catherine B; Bergeron, Anne; Shoham, Shmuel; Ljungman, Per; Waghmare, Alpana; Blanchard, Elodie; Kim, Yae-Jean; McKevitt, Matt; Porter, Danielle P; Jordan, Robert; Guo, Ying; German, Polina; Boeckh, Michael; Watkins, Timothy R; Chien, Jason W; Dadwal, Sanjeet S
Title: A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract Document date: 2019_12_3
ID: sl45z4i0_33
Snippet: The mechanism of action of presatovir may also have limited efficacy in this study. Because RSV is capable of cell-to-cell spread, inhibition of viral fusion may not halt propagation of established infection along the respiratory tract. Therefore, fusion inhibitors, such as presatovir, may need to be administered, whereas virus-cell fusion still represents the main mode of viral spread to appreciably reduce nasal viral load. Emergence of F gene p.....
Document: The mechanism of action of presatovir may also have limited efficacy in this study. Because RSV is capable of cell-to-cell spread, inhibition of viral fusion may not halt propagation of established infection along the respiratory tract. Therefore, fusion inhibitors, such as presatovir, may need to be administered, whereas virus-cell fusion still represents the main mode of viral spread to appreciably reduce nasal viral load. Emergence of F gene protein amino acid substitutions associated with fusion inhibitor resistance was also relatively frequent (21%) in this immunocompromised population. Polymerase inhibitors can terminate intracellular RSV replication and may have wider Data are n (%) unless otherwise specified.
Search related documents:
Co phrase search for related documents- amino acid and cell cell spread: 1, 2, 3, 4, 5, 6, 7, 8
- amino acid and establish infection: 1, 2, 3
- amino acid and fusion inhibitor: 1, 2, 3, 4, 5, 6, 7, 8
- amino acid and nasal viral load: 1
- amino acid and polymerase inhibitor: 1, 2
- cell cell and establish infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cell cell and fusion inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- cell cell and limit efficacy: 1, 2, 3
- cell cell and nasal viral load: 1
- cell cell and polymerase inhibitor: 1, 2, 3
- cell cell spread and fusion inhibitor: 1
- establish infection and fusion inhibitor: 1, 2
- fusion inhibitor and nasal viral load: 1, 2, 3
- fusion inhibitor and polymerase inhibitor: 1, 2, 3, 4
- nasal viral load and polymerase inhibitor: 1, 2
Co phrase search for related documents, hyperlinks ordered by date